MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.02B
Enterprise Value 34.1B
Trailing P/E N/A
Forward P/E 16.11
PEG Ratio (5 yr expected) 11.57
Price/Sales (ttm)0.56
Price/Book (mrq)0.72
Enterprise Value/Revenue 31.12
Enterprise Value/EBITDA 67.59

Trading Information

Stock Price History

Beta (3Y Monthly) 1.10
52-Week Change 3-47.10%
S&P500 52-Week Change 34.88%
52 Week High 348.77
52 Week Low 322.79
50-Day Moving Average 325.09
200-Day Moving Average 329.47

Share Statistics

Avg Vol (3 month) 3943.36k
Avg Vol (10 day) 3631.03k
Shares Outstanding 586.54M
Float 82.31M
% Held by Insiders 13.29%
% Held by Institutions 197.12%
Shares Short (Jun 28, 2019) 44.74M
Short Ratio (Jun 28, 2019) 44.77
Short % of Float (Jun 28, 2019) 46.23%
Short % of Shares Outstanding (Jun 28, 2019) 45.48%
Shares Short (prior month May 31, 2019) 44.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Dec 20, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -1.03%
Operating Margin (ttm)11.74%

Management Effectiveness

Return on Assets (ttm)4.62%
Return on Equity (ttm)8.45%

Income Statement

Revenue (ttm)3.65B
Revenue Per Share (ttm)40.78
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)1.03B
EBITDA 539.58M
Net Income Avi to Common (ttm)250.28M
Diluted EPS (ttm)-0.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.7M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)2.22B
Total Debt/Equity (mrq)79.70
Current Ratio (mrq)2.55
Book Value Per Share (mrq)32.67

Cash Flow Statement

Operating Cash Flow (ttm)346.74M
Levered Free Cash Flow (ttm)-28.89M